Aptevo Therapeutics : Announces Monotherapy Patient Received a Transplant in APVO436 Expansion Trial for the Treatment of Acute Myeloid Leukemia
Patients in Both Monotherapy and Combination Arms in Multi-Cohort Trial Have Achieved Transplant Eligible Status SEATTLE, WA / ACCESSWIRE / March 29, 2022 / Aptevo Therapeutics... | March 29, 2022
United States Miriam Weber Miller Dirk Huebner Justin Watts Exchange Commission American Society Of Hematology
Source: marketscreener.com